Skip to the content
Biojivalogo darklogo light
  • about
  • product
  • science
  • team
  • publications
  • contact
Search
Biojiva
  • about
  • product
  • science
  • team
  • publications
  • contact
Biojiva
  • about
  • product
  • science
  • team
  • publications
  • contact
Home2018April
Movement Disorders 2018-06
Publications

Randomized, clinical trial of RT001: early signals of efficacy in Friedreich’s ataxia

BioJiva
April 6, 2018
Other Publications:

Deuterated docosahexaenoic acid protects against oxidative stress and geographic atrophy-like retinal degeneration in a mouse model with iron overload

BioJiva
March 8, 2022

Plasma and RBC cell membrane accretion and PK of RT001

BioJiva
November 30, 2020

Site-specifically deuterated essential lipids as new drugs against neuronal, retinal and vascular degeneration

BioJiva
August 1, 2020

PUFA deuteration against neurodegeneration

BioJiva
April 1, 2020

Treatment of INAD with RT001: a di-deuterated ethyl ester of linoleic acid. Report of two cases

BioJiva
March 27, 2020

Applications of Deuterium in medicinal chemistry

BioJiva
January 14, 2019
© 2025 BioJiva, LLC – All Rights Reserved – 3590 N First St Suite 320, San Jose, CA 95134 – Website by emago media
Back to top Drag
w